Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma: A Systematic Review and Network Meta-analysis

IMPORTANCE: Since 2011, immune checkpoint inhibitors (ICIs) have been effective treatment options for advanced melanoma. Little is known about how risks of immune-related adverse events (irAEs) vary by ICIs. OBJECTIVE: To compare the risk of irAEs across different treatment regimens for advanced mel...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ching-Yuan, Park, Haesuk, Malone, Daniel C., Wang, Ching-Yu, Wilson, Debbie L., Yeh, Yu-Min, Van Boemmel-Wegmann, Sascha, Lo-Ciganic, Wei-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097702/
https://www.ncbi.nlm.nih.gov/pubmed/32211869
http://dx.doi.org/10.1001/jamanetworkopen.2020.1611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7097702/
https://www.ncbi.nlm.nih.gov/pubmed/32211869
http://dx.doi.org/10.1001/jamanetworkopen.2020.1611

Ejemplares similares